Multiple Myeloma: Extension of Approval for subcutaneous Administration of Daratumumab

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [1] Subcutaneous Administration of Daratumumab for Myeloma Under Investigation
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 7 - 8
  • [2] Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Multiple Myeloma Patients at Mayo Clinic
    Soefje, Scott
    Carpenter, Corinne
    Carlson, Katherine
    Awasthi, Samir
    Lin, Thomas S.
    Kaila, Shuchita
    Tarjan, Daniel
    Kayal, Nikhil
    Kirkup, Christian
    Wagner, Tyler
    Gray, Kathleen
    Kumar, Shaji
    [J]. BLOOD, 2021, 138
  • [3] Daratumumab subcutaneous formulation for the treatment of multiple myeloma
    Paul, Barry
    Hamadeh, Issam
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter
    Usmani, Saad Z.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1253 - 1259
  • [4] An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma
    Paul, Barry
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter
    Hamadeh, Issam
    Usmani, Saad Z.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 795 - 802
  • [5] Subcutaneous versus intravenous daratumumab in multiple myeloma
    Shibusawa, Motoharu
    Tanimoto, Tetsuya
    [J]. LANCET HAEMATOLOGY, 2020, 7 (08): : E558 - E558
  • [6] Real-world observations and practical considerations of subcutaneous daratumumab administration in multiple myeloma
    Kim, E. Bridget
    O'Donnell, Elizabeth
    Branagan, Andrew
    Burke, Jill
    Harrington, Cynthia
    Agyemang, Emerentia
    Raje, Noopur
    Yee, Andrew J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S40 - S40
  • [7] Real-World Observations and Practical Considerations of Subcutaneous Daratumumab Administration in Multiple Myeloma
    Kim, Panel e. Bridget
    O'Donnell, Elizabeth
    Branagan, Andrew R.
    Burke, Jill N.
    Harrington, Cynthia C.
    Agyemang, Emerentia
    Raje, Noopur S.
    Yee, Andrew J.
    [J]. BLOOD, 2021, 138
  • [8] Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
    Usmani, Saad Z.
    Nahi, Hareth
    Mateos, Maria-Victoria
    van de Donk, Niels W. C. J.
    Chari, Ajai
    Kaufman, Jonathan L.
    Moreau, Philippe
    Oriol, Albert
    Plesner, Torben
    Benboubker, Lotfi
    Hellemans, Peter
    Masterson, Tara
    Clemens, Pamela L.
    Luo, Man
    Liu, Kevin
    San-Miguel, Jesus
    [J]. BLOOD, 2019, 134 (08) : 668 - 677
  • [9] Subcutaneous versus intravenous daratumumab in multiple myeloma reply
    Mateos, Maria-Victoria
    Usmani, Saad Z.
    [J]. LANCET HAEMATOLOGY, 2020, 7 (08): : E559 - E559
  • [10] First-line Approval: Daratumumab VMP in multiple Myeloma
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (12) : 794 - 794
12345